Valuation Square Pharmaceuticals PLC.

Stocks

End-of-day quote Dhaka S.E. 2026-11-03			5-day change	1st Jan Change
215.60 ^BDT	-0.37%		-1.46%	+8.56%

10-26	Square Pharmaceuticals plc announces Annual dividend, payable on January 14, 2027	CI
04-30	Square Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	191,030	192,094	185,977	186,953	185,180	191,119	-	-
Change	-	0.56%	-3.18%	0.52%	-0.95%	3.21%	-	-
Enterprise Value (EV)	147,770	140,679	137,870	186,953	185,180	191,119	191,119	191,119
Change	-	-4.8%	-2%	35.6%	-0.95%	3.21%	0%	0%
P/E	12x	10.6x	9.8x	8.93x	7.73x	7.29x	6.49x	5.8x
PBR	2.1x	1.86x	1.61x	1.48x	-	1.22x	1.11x	1x
PEG	-	0.8x	2.23x	0.9x	0.5x	0.77x	0.5x	0.5x
Capitalization / Revenue	3.77x	3.34x	2.96x	2.67x	-	2.25x	2.02x	1.83x
EV / Revenue	0x	0x	0x	0x	-	2.25x	2.02x	1.83x
EV / EBITDA	0x	0x	0x	0x	-	7.37x	6x	5.23x
EV / EBIT	0x	0x	0x	0x	-	8.08x	6.86x	6.13x
EV / FCF	0x	0x	0x	0x	-	10x	8.29x	7.35x
FCF Yield	3.78%	5.06%	3.08%	7.67%	-	9.98%	12.1%	13.6%
Dividend per Share ²	6	10	10.5	11	-	-	-	-
Rate of return	2.78%	4.61%	5%	5.22%	-	-	-	-
EPS ²	17.99	20.51	21.41	23.61	27.04	29.6	33.22	37.16
Distribution rate	33.4%	48.8%	49%	46.6%	-	-	-	-
Net sales ¹	50,703	57,598	62,748	70,101	-	85,112	94,788	104,516
EBITDA ¹	18,009	20,218	20,651	21,455	-	25,920	31,853	36,553
EBIT ¹	16,126	18,383	18,341	19,137	-	23,639	27,875	31,186
Net income ¹	14,743	16,417	18,858	20,926	-	26,600	29,572	32,733
Net Debt	-43,260	-51,415	-48,107	-	-	-	-	-
Reference price ²	215.50	216.70	209.80	210.90	208.90	215.60	215.60	215.60
Nbr of stocks (in thousands)	886,451	886,451	886,451	886,451	886,451	886,451	-	-
Announcement Date	11/25/21	12/4/22	11/22/23	11/27/24	11/20/25	-	-	-

¹BDT in Million²BDT

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SQUARE PHARMACEUTICALS PLC.	7.31x	-	-	-	1.54B
ELI LILLY AND COMPANY	41.24x	13.98x	31x	0.48%	1,257B
JOHNSON & JOHNSON	39.6x	6.65x	18.71x	1.97%	651B
ABBVIE INC.	36.2x	8.44x	17.42x	2.4%	510B
ROCHE HOLDING AG	21.41x	5.2x	12.95x	2.52%	388B
MERCK & CO., INC.	98.19x	6.02x	25.62x	2.29%	366B
NOVARTIS AG	22.92x	5.89x	14.21x	2.72%	303B
ASTRAZENECA PLC	24.43x	4.89x	13.76x	1.79%	288B
AMGEN INC.	29.52x	7.52x	13.46x	2.17%	252B
GILEAD SCIENCES, INC.	-40.78x	7.43x	46.67x	1.94%	211B
Average	28.01x	7.34x	21.53x	2.03%	422.82B
Weighted average by Cap.	36.22x	8.78x	22.70x	1.71%